You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KNSA Exercise Disclosure
Paolini John F. · SEC Form 4 · Filed Sep 3, 2026
Exercise
Reported value range
Not reported
Paolini John F. Chief Medical Officer
KNSA
Transaction date
Sep 1, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed 2 days later
KNSA daily price context
Close on/before transaction
$79.28
Sep 1, 2026
First close after public filing
$77.91
Sep 4, 2026
30-day return after filing
-2.05%
Through Oct 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Ordinary Share
- Quantity / price
- 2,457 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001741533-26-000010
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$319.42K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc KNSA | Exercise | Sep 1, 2026 | Not reported |
| Kiniksa Pharmaceuticals International, Plc KNSA | Exercise | Sep 1, 2026 | Not reported |
| Kiniksa Pharmaceuticals International, Plc KNSA | Exercise | Sep 1, 2026 | Not reported |
| Kiniksa Pharmaceuticals International, Plc KNSA | Disposition | Sep 1, 2026 | $319.42K |
| Kiniksa Pharmaceuticals International, Plc KNSA Current | Exercise | Sep 1, 2026 | Not reported |
| Kiniksa Pharmaceuticals International, Plc KNSA | Award | Sep 1, 2026 | $0 |
| Kiniksa Pharmaceuticals International, Plc KNSA | Award | Sep 1, 2026 | $0 |
| Kiniksa Pharmaceuticals International, Plc KNSA | Exercise | Sep 1, 2026 | $0 |
| Kiniksa Pharmaceuticals International, Plc KNSA | Exercise | Sep 1, 2026 | $0 |
| Kiniksa Pharmaceuticals International, Plc KNSA | Exercise | Sep 1, 2026 | $0 |
| Kiniksa Pharmaceuticals International, Plc KNSA | Exercise | Sep 1, 2026 | $0 |